# Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment

> **NCT03619668** · — · UNKNOWN · sponsor: **Aalborg University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Rectal Cancer
- Rectal Adenocarcinoma
- Locally Advanced Malignant Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03619668
- **Lead sponsor:** Aalborg University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-29
- **Primary completion:** 2022-02-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03619668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03619668, "Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03619668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*